Comments

Anebulo Pharmaceuticals

ANEBNASDAQ
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$2.76
0.5625.45%
Pre-Market: Jun 27, 9:26 AM EDT
15 minutes delayed
Anebulo Pharmaceuticals (ANEB) ForecastNewsEarningsGuidanceDividends

Analyst Ratings

Insider TradesShort Interest
Consensus Rating1
Buy
Highest Price Target1
$8.00
Lowest Price Target1
$6.00
Consensus Price Target1
$6.50

Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Click Here

Anebulo Pharmaceuticals (NASDAQ:ANEB) Stock, Analyst Ratings, Price Targets, Forecasts

Anebulo Pharmaceuticals Inc has a consensus price target of $6.5 based on the ratings of 4 analysts. The high is $8 issued by Benchmark on October 3, 2023. The low is $6 issued by HC Wainwright & Co. on September 25, 2023. The 3 most-recent analyst ratings were released by Benchmark, HC Wainwright & Co., and Maxim Group on October 3, 2023, September 25, 2023, and September 21, 2023, respectively. With an average price target of $6.67 between Benchmark, HC Wainwright & Co., and Maxim Group, there's an implied 141.55% upside for Anebulo Pharmaceuticals Inc from these most-recent analyst ratings.

Analyst Rating and Forecast
12345
3.0
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Benchmark
HC Wainwright & Co.
Maxim Group
Ladenburg Thalmann

1calculated from analyst ratings

Analyst Ratings for Anebulo Pharmaceuticals

Buy NowGet Alert
10/03/2023Buy Now189.86%Benchmark
Robert Wasserman
 → $8ReiteratesSpeculative Buy → Speculative BuyGet Alert
09/25/2023Buy Now117.39%HC Wainwright & Co.
Raghuram Selvaraju
 → $6ReiteratesBuy → BuyGet Alert
09/21/2023Buy Now117.39%Maxim Group
Michael Okunewitch
 → $6Initiates → BuyGet Alert
09/18/2023Buy Now117.39%HC Wainwright & Co.
Raghuram Selvaraju
 → $6Initiates → BuyGet Alert
05/18/2023Buy Now189.86%Benchmark
Robert Wasserman
 → $8ReiteratesSpeculative Buy → Speculative BuyGet Alert
02/14/2023Buy Now189.86%Benchmark
Robert Wasserman
$10 → $8MaintainsSpeculative BuyGet Alert
07/27/2022Buy Now117.39%Ladenburg Thalmann
Aydin Huseynov
 → $6Initiates → BuyGet Alert

FAQ

Q

What is the target price for Anebulo Pharmaceuticals (ANEB) stock?

A

The latest price target for Anebulo Pharmaceuticals (NASDAQ:ANEB) was reported by Benchmark on October 3, 2023. The analyst firm set a price target for $8.00 expecting ANEB to rise to within 12 months (a possible 189.86% upside). 4 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Anebulo Pharmaceuticals (ANEB)?

A

The latest analyst rating for Anebulo Pharmaceuticals (NASDAQ:ANEB) was provided by Benchmark, and Anebulo Pharmaceuticals reiterated their speculative buy rating.

Q

When was the last upgrade for Anebulo Pharmaceuticals (ANEB)?

A

There is no last upgrade for Anebulo Pharmaceuticals

Q

When was the last downgrade for Anebulo Pharmaceuticals (ANEB)?

A

There is no last downgrade for Anebulo Pharmaceuticals.

Q

When is the next analyst rating going to be posted or updated for Anebulo Pharmaceuticals (ANEB)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Anebulo Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Anebulo Pharmaceuticals was filed on October 3, 2023 so you should expect the next rating to be made available sometime around October 3, 2024.

Q

Is the Analyst Rating Anebulo Pharmaceuticals (ANEB) correct?

A

While ratings are subjective and will change, the latest Anebulo Pharmaceuticals (ANEB) rating was a reiterated with a price target of $0.00 to $8.00. The current price Anebulo Pharmaceuticals (ANEB) is trading at is $2.76, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch